Cargando…
Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution
The risk of severe adverse events related to thiopurine therapy can be reduced by personalizing dosing based on TPMT and NUDT15 genetic polymorphisms. However, the optimal genetic testing platform has not yet been established. In this study, we report on the TPMT and NUDT15 genotypes and phenotypes...
Autores principales: | Cook, Kelsey J., Grusauskas, Victoria, Gloe, Lucy, Duong, Benjamin Q., Gresh, Renee C., Kolb, E. Anders, Bansal, Manisha, Bechtel, Allison S., Nagasubramanian, Ramamoorthy, Kirwin, Susan M., Blake, Kathryn V., Seligson, Nathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432880/ https://www.ncbi.nlm.nih.gov/pubmed/37415296 http://dx.doi.org/10.1111/cts.13539 |
Ejemplares similares
-
Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease
por: Wang, Hong-Hui, et al.
Publicado: (2018) -
Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn’s disease
por: Lee, Ji Hyeon, et al.
Publicado: (2017) -
Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia
por: Correa-Jimenez, Oscar, et al.
Publicado: (2021) -
TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned
por: Goh, Liuh Ling, et al.
Publicado: (2022) -
Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT
por: Park, Yoomi, et al.
Publicado: (2020)